Main Menu


Welcome to BOPA

Latest news from BOPA

New Patient Safety Alert On Non-Luer Devices For Spinal (intrathecal) Chemotherapy

A new Patient Safety Alert was issued yesterday concerning Non-Luer Devices for Spinal (Intrathecal) Chemotherapy. This guidance replaces that in previous Alerts concerning devices for chemotherapy. All other guidance in previous Alerts concerning other device types remains unchanged.

Please see link: http://www.england.nhs.uk/2014/02/20/psa-spinal-chemo

A Neuraxial Update Newsletter will be published shortly.

We hope to arrange the first meeting of the new Small Bore Connector Clinical Advisory Group in the next few months, terms of reference available in the BOPA Forum.


NHS England: Principles for sharing benefits with more efficient use of medicines

NHS England ‘Principles for sharing the benefits associated with more efficient use of medicines not reimbursed through national prices.’
http://www.england.nhs.uk/wp-content/uploads/2014/01/princ-shar-benefits.pdf

Medicines Optimisation CRG for specialist services has supported the publication of the above document. The overarching aim for NHS England commissioned drugs (not covered by tariff) is that there is a move towards a consistent approach to gain sharing.

Any thoughts / comments / questions in relation to this document please send to Rob Duncombe. Robert.duncombe@christie.nhs.uk

Read More

Clinical Academic Research Training Funding available for pharmacists

Following the work of Health Education England’s (HEE) newly established Clinical Academic Careers Stakeholder Group to review the NIHR / HEE Clinical Academic Training Programme, we are pleased to confirm that pharmacists are now eligible to apply for NIHR / HEE Clinical Doctoral Research Fellowships and NIHR / HEE Masters in Clinical Research places on the programme.  The NIHR / HEE CAT Programme is now open to pharmacists, in addition to nurses, midwives and AHPs as part of a pilot looking at increasing the professions which are eligible to apply through the programme.  Further work will continue as part of the review by the Stakeholder Group. This funding will provide pharmacists with an opportunity to sustain and develop clinical skills while becoming proficient researchers.

http://www.rpharms.com/what-s-happening-/news_show.asp?id=1034

The BOPA Audit and Research Committee will be discussing this development, and ways in which BOPA can help members get involved in research and apply for funding.


For older news items please click here


To pay your conference fees

2013 BOPA Conference fees
2014 BOPA Conference fees